Early detection of breast cancer gives the best possible chance of survival. The earlier an abnormality is discovered, the greater the number of effective treatment options available. This ensures the best possible outcome. It is essential that women of all ages understand the importance of detecting and treating breast cancer early.
Even after breast cancer has been diagnosed, novel and innovative detection methods may be used to monitor a patient’s progress and treatment effectiveness. One rapidly developing research field in detection is liquid biopsies (for example blood samples). One application of liquid biopsy technology could be the ability to monitor a patient’s therapeutic response through detecting traces of breast cancer DNA in the blood.
The research that we fund
NBCF funds groundbreaking research that develops state-of-the-art technology to improve early breast tumour detection using mammography and other alternative technologies. We also fund pioneering research projects that develop innovative detection methods for improved breast cancer surveillance, management and treatment.